Understanding the biology of the previously underappreciated sensitivity of cochlear synapses to noise insult, and its clinical consequences, is becoming a mission for a growing number of auditory researchers. In addition, several research groups have become interested in developing therapeutic approaches that can reverse synaptopathy and restore hearing function. One of the major challenges to realizing the potential of synaptopathy rodent models is that current clinical audiometric approaches cannot yet reveal the presence of this subtle cochlear pathology in humans. This has catalyzed efforts, both from basic and clinical perspectives, to investigate novel means for diagnosing synaptopathy and to determine the main functional consequences for auditory perception and hearing abilities. Such means, and a strong concordance between findings in pre-clinical animal models and clinical studies in humans, are important for developing and realizing therapeutics. This paper frames the key outstanding translational questions that need to be addressed to realize this ambitious goal.
Introduction
Cochlear synaptopathy was defined and characterized in a study of young adult mice (16 week, male CBA/CaJ) exposed to a temporary threshold shift-(TTS) inducing noise (8e16 kHz octaveband noise at 100 dB SPL, 2 h) (Kujawa and Liberman, 2009 ). In this model, sensory hair cells recover and remain intact throughout virtually the entire length of the cochlea, yet a subset of synapses between inner hair cells (IHCs) and cochlear afferent nerve fibers are immediately and permanently lost. The key features of this model are: 1) Partial loss of IHC synapses, quantitated from histological assessment using pre-and post-synaptic markers 2) Normal threshold sensitivity measured by auditory brainstem response (ABR) and distortion product otoacoustic emissions (DPOAEs) at frequencies tonotopically related to locations of synaptic loss
3) Reduced amplitude of wave 1 of the ABR, measured using moderate-to high-level tone stimuli, at frequencies tonotopically related to locations of synaptic loss
The first aspect of the phenotype, histological evidence for reduced numbers of cochlear afferent synapses, is the only direct verification of synaptopathy. When observed together, the remaining attributes of the physiologic phenotype (numbers 2 and 3) serve as a non-invasive proxy for primary synaptic loss. Functional recovery of sensory cells, both IHCs and outer hair cells (OHCs), underlies recovery of auditory thresholds as defined by ABR and OAE measurements. The establishment of normal cochlear sensitivity is critical to the interpretation of ABR wave 1 amplitude reductions at moderate to high stimulus levels as a proxy for primary synaptopathy. If cochlear sensitivity is reduced due to OHC dysfunction, then changes in ABR wave 1 amplitude can no longer be attributed solely to a loss of IHC synapses as they will reflect the combination of more distributed cochlear damage. The study of cochlear synaptopathy has primarily been driven by experiments that investigated noise-induced injury in mouse models (Table 1) . However, in recent years, the constellation of findings associated with synaptopathy have also been observed in guinea pig (Lin et al., 2011; Furman et al., 2013) , chinchilla ( Fig. 1 ) and rat ( Fig. 2) . In addition to noise exposure, both aging (Sergeyenko et al., 2013; Altschuler et al., 2015; M€ ohrle et al., 2016) and administration of ototoxins (Bourien et al., 2014; Li et al., 2016) have also been associated with cochlear synaptopathy, suggesting that the Type I synapse may be a particularly vulnerable link in the inner-ear circuit. Table 1 details forty-three studies that have reported anatomically confirmed synaptopathy in rodents. In all cases, synaptopathy was corroborated through visualization of fluorescently labeled antibodies to C-terminal binding protein 2 (CtBP2) in the basolateral regions of IHCs, representing the synaptic isoform of the CtBP2 protein ("ribeye"). These CtBP2-positive puncta serve as a histological marker for quantifying pre-synaptic ribbons, thus the presence of fewer puncta is used to quantitatively define presynaptic loss. Roughly half (21 of 43) of these experiments improved the accuracy of estimating synapse number by additionally using antibodies against post-synaptic glutamate receptors such as GluA2, GluA2/3 or PSD-95, which reduces overestimation of synapse counts by flagging "orphans" (pre-synaptic ribbons that lack a post-synaptic connection). Counts of both pre-and postsynaptic markers may differ by anywhere from a few percent (Furman et al., 2013) to over 50% (Bailey and Green, 2014; Bourien et al., 2014 ) depending on the study or the nature of cochlear insult, underscoring the need for quantifying complete synapses (pre and post) in relating histological observations to functional readouts for synaptopathy.
Table 1 also demonstrates that synaptopathy has been equally studied with and without other measurable cochlear damage. Twenty-four of the synaptopathy reports employed experimental models that drove restricted damage to IHC synapses in select frequency regions or experimental conditions, as evidenced by a physiological phenotype that included normal sensitivity at some or all cochlear regions of synapse loss (Table 1 , rows 1e24). These models are useful for defining the environmental conditions that specifically cause synapse loss and the physiological consequences of disturbing this inner-ear circuit. But just as many synaptopathy reports used models that also included some loss of cochlear sensitivity (Table 1 , rows 7e32, and see Figs. 1 and 2 ). Comparing physiologic phenotypes in synaptopathy-restricted and synaptopathy-plus-cochlear-damage models will allow differentiation of the consequences that are directly attributable to synaptopathy per se versus those that include more widespread cochlear damage, and the latter may be typical in humans who experience less controlled environmental exposures. A few studies restricted their assessment of cochlear sensitivity to broadband-elicited ABR, using click or noise-burst stimuli, which does not allow straightforward comparison between cochlear synaptopathy region and physiologically defined sensitivity, and others did not report the cochlear sensitivity of their models. Additionally, some studies reported synaptic counts based on cochlear segment or distance along the cochlear duct, without relation to established cochlear frequency maps. In these cases, there is insufficient information to drive detailed interpretation and comparison between histological and physiological outcomes.
Noise-induced synaptic loss is generally believed to be permanent; however, a few reports have suggested that synaptic loss may be partially reversible at early time points post-insult Liu et al., 2015) . Nonetheless, even in these models, synaptic counts are consistently reduced weeks after noise exposure, reinforcing the long-term irreversibility of synaptic loss without therapeutic intervention. Cochlear synapse vulnerability related to aging and environmental factors has now been observed across several laboratories and animal models, lending credence to the idea that synaptopathy may be a common feature of sensorineural hearing loss in humans. Type I synaptic losses would be expected to degrade important perceptual computations (e.g. signal-in-noise extraction) and might provide some anatomical account for commonly observed hearing difficulties. Seeking to better understand the phenotype, its impact on hearing abilities, and options for accurate clinical diagnosis will be critical steps towards the development of therapeutics.
What makes the synapses of low-SR fibers particularly vulnerable?
Observations in guinea pig (Furman et al., 2013) and mouse have demonstrated that low spontaneous-rate (SR), high-threshold fibers are more susceptible to noise damage compared to high-SR, low-threshold fibers. These observations provide a parsimonious explanation for how suprathreshold ABR responses are reduced in the absence of threshold elevations in restricted synaptopathy models. There are intrinsic and extrinsic mechanisms that may contribute to post-synaptic low-SR fiber susceptibility to excitotoxicity, such as differences in mitochondrial count and proximity to local glutamate uptake mechanisms in low-SR compared to high-SR fibers (for discussion, see Kujawa and Liberman, this issue) . Differences in the presynaptic machinery adjacent to low-vs. high-SR fibers may also Table 1 Forty-three studies reporting histological evidence for vulnerability of IHC synapses to a variety of cochlear insults, and physiological approaches used to assess auditory functional impairment. Studies were selected to represent methods for inducing synaptopathy in readily available animal models or strains. Studies may be listed more than once: in some cases where more than one method was used (e.g. noise exposure and aging), data may be reported for each method separately or combined. Studies reporting data from transgenic lines, which often have mixed or undetermined genetic backgrounds, are not considered here for simplicity. Percent reduction in synaptic components and in supra-threshold evoked responses is estimated from group mean data from figures, or from tables or text where available. Supra-threshold amplitude reduction is estimated using data at the highest SPLs reported in the study, or where response plateaus for input/output functions. DPOAE amplitudes are not considered in this table, only DPOAE thresholds. "no quant" indicates that both pre-and post-synaptic markers were used in the study, but quantification is not necessarily reported separately. Check mark indicates that data are reported in support of the criteria in the column header, while X indicates that data are reported that do not support the conclusion in the column header. Both are possible for a single study, for example if thresholds are recovered for certain frequency/locations but remain elevated for others. Double XX indicates that ABR thresholds are not elevated, but that CAP data in the same study suggest elevated neural thresholds. "Normal/recovered" vs "elevated" threshold classification determined by statistical evidence provided in the study, or otherwise determined by overlap or lack of overlap in group mean variances. Where studies report data from multiple timepoints post-noise-exposure, data are included in the Table for timepoints of 1 week or greater, to avoid the confound of temporary threshold shifts. Dash indicates item not measured or not reported. "n.r" indicates item was measured, but is not relatable to histological data for one of the following reasons: 1) histological approach does not explicitly relate location to cochlear frequency; 2) physiological stimuli are not frequency-specific (e.g. clicks or noise-bursts); 3) conflicting statements are made regarding cochlear location studied. contribute to differential sensitivity to excitotoxicity; for example, a larger number of Ca 2þ channels in the pre-synaptic active zone are positioned to facilitate larger magnitude neurotransmitter release opposite to low-SR compared to high-SR fibers (Ohn et al., 2016) . However, Bourien et al. (2014) showed that low-SR fibers can also be preferentially damaged with local delivery of ouabain, a Naþ/Kþ-ATPase inhibitor that induces apoptosis in spiral ganglion neurons (SGNs) while sparing sensory cells (Lang et al., 2005) . In this study, application of ouabain to gerbil round window reduced the number of IHC synapses in a dose-dependent manner, and complementary single-fiber recordings in cochlear nerve revealed a reduced proportion of low-SR fibers for the lowest dose of ouabain, particularly in high-frequency cochlear regions. Thus, low-SR fiber sensitivity to damage is not restricted to acute excitotoxic insult. Similarly, a single-fiber physiology study in aging gerbils also revealed a disproportionately low number of low-SR fibers in older animals, again for higher frequency regions of the cochlea (Schmiedt et al., 1996) . Understanding the basis for why a subpopulation of cochlear afferent fibers is more easily damaged than others can inform pre-clinical studies for protecting or restoring IHC synapses, which will in turn provide potential avenues for therapies that target neural connectivity in the cochlea.
3. Are the neurophysiological properties of low-SR fibers in humans similar to those in animals, and are low-SR fibers in humans similarly vulnerable?
Low-and medium-SR fibers (<~20 spikes/second, typically grouped together as "low-SR") comprise roughly 40% of the total population of Type I SGN fibers, with high-SR fibers (>~20 spikes/ second) comprising the rest. Across several animal species, including cat, chinchilla, mouse, guinea pig, and gerbil, this distribution remains approximately constant, although the shape of the distribution may differ depending on the species (Liberman, 1978; Relkin and Doucet, 1991; Taberner and Liberman, 2004; Sumner and Palmer, 2012; Furman et al., 2013; Bourien et al., 2014) . Similarly, the fundamental relationship between fiber SR and fiber threshold, wherein low-SR fibers have higher thresholds and thus encode stimuli at higher sound pressure levels, has been observed in several species including cat, guinea pig, gerbil and mouse (Liberman, 1978; Evans and Palmer, 1980; Tsuji and Liberman, 1997; Taberner and Liberman, 2004; Huet et al., 2016) . However, a singleunit physiology study in a non-human primate (macaque) did not replicate this observed relationship between the spontaneous firing rates and thresholds of auditory nerve fibers (Joris et al., 2011) . This contrast between what has been observed in rodents and what is observed in the non-human primate calls into question whether this distinction between low-SR and high-SR subtypes might also exist in humans. Clearly, further study of synaptopathy Threshold Shift (dB)
107 dB 104 dB 100-101 dB 98-99 dB Unexposed Fig. 1 . Cochlear synaptopathy in chinchilla. Adult (6e7 mo) male chinchillas were exposed, awake and unrestrained, to an octave-band noise centered at 1 kHz for 2 h, at levels ranging from 98 to 107 dB SPL (animals per group: 98e99 dB: 2, 100e101 dB: 2, 104 dB: 2, 107 dB: 2, unexposed: 7 total, 2 of which were also characterized physiologically). Ears from exposed chinchillas and from unexposed, age-and sex-matched controls were examined by immunolabeling and confocal microscopy to quantitate CtBP2-positive synaptic ribbons as described in Kujawa and Liberman, 2009 . Top: Synaptic-ribbon counts were reduced in exposed ears relative to controls, for all exposure levels tested, for mid-and mid-basal cochlear regions. Comparison with ABR threshold shifts in the same ears (bottom) (2 wks post-exposure relative to baseline) demonstrates that cochlear synaptopathy is evident both in cases of TTS and PTS. Key in top panel applies to both. Gray bar indicates noise exposure band. Hickox, Liberman and Heinz, unpublished. Post-exposure Pre-exposure Fig. 2 . Cochlear synaptopathy in rat. Adult (~250 g) male rats were exposed, anesthetized with ketamine and xylazine, to a two-octave band noise centered at 8 kHz for 1 h at 119 dB SPL (animals per group: 119 dB: 4, unexposed: 4). Ears from exposed rats and from unexposed, age-and sex-matched controls were examined by immunolabeling and confocal microscopy to quantitate CtBP2-positive synaptic ribbons as described in Kujawa and Liberman, 2009 . Top: Synaptic ribbon counts were reduced in exposed ears relative to controls for mid-and basal cochlear regions. Comparison with DPOAE amplitudes in the exposed ears (bottom) (10 d post-exposure, red; baseline, black) demonstrates that cochlear synaptopathy is evident both in cases of recovered and impaired cochlear sensory cell function. Gray bar indicates noise exposure band. Decibel Therapeutics, unpublished. models in non-human primates will be important in determining whether selective low-SR loss is expected in humans and which non-invasive proxies for synaptopathy provide the most information concerning inner ear health.
4. What clinical tests might be suitable for diagnosing synaptopathy in humans? Can tests for cochlear synaptopathy successfully differentiate consequences of synaptic loss from other cochlear damage?
In cases of restricted synaptopathy, where synapse loss is observed in a region with normal hair-cell appearance and normal thresholds, reduced ABR wave 1 amplitude at moderate to high sound levels remains a faithful indicator of fewer functional synapses (Kujawa and Liberman, 2009 ). It would be convenient to use the same evoked response from human listeners to detect synaptopathy, but the amplitudes and latencies of individual ABR waves vary considerably across humans (Trune et al., 1988) , making the absolute ABR wave I amplitude less attractive as the basis for a diagnostic assay. One approach to reducing this inter-subject variability is to normalize by the hair-cell-generated summating potential that precedes ABR wave I. In one study, this normalized potential appeared to scale with reported noise-exposure history and was modestly correlated with speech-in-noise performance, both of which are at least consistent with expectations of synaptic loss ). An alternative is to focus on tests that may highlight contribution from low-SR fibers in steady-state responses. In inbred mice, Shaheen et al. (2015) observed that the amplitude and phase locking of the envelope-following response to a temporally modulated signal was more sensitive to neuropathy than ABR wave 1 onset responses when the stimulus parameters were optimized. Presumably the benefit of relying on steady-state rather than onset measurements would be even more pronounced in humans, given the increase in size-and tissueconductance variability compared to mice, but that proposition currently remains untested.
Animal models of noise-induced cochlear synaptopathy typically use exposure stimuli targeting mid-to basal cochlear regions, reliably leading to acute basal synaptopathy, although with time, more apical synaptopathy can be observed (Fernandez et al., 2015; Jensen et al., 2015) . However, in many of these models, some degree of sensory cell damage is reported in the extreme cochlear base, whether by slight OHC loss or small but significant threshold shifts for the highest frequencies tested (Kujawa and Liberman, 2009; Hickox and Liberman, 2014; Jensen et al., 2015; Shaheen et al., 2015; Suzuki et al., 2016; Valero et al., 2016) . The vulnerability of hair cells in the extreme base has been known for some time (Johnsson and Hawkins, 1972) . More recently, in vitro experimentation has shown this may also arise in part from an inherent sensitivity of the basally positioned cells, in addition to their location in a vulnerable cochlear region (Sha et al., 2001) . Because high-frequency hearing loss is a common and largely inevitable feature of aging human ears (Dubno et al., 2013) , these data raise the question of how likely it is that a restricted synaptopathy may arise in middle-aged to older humans without sensory cell or metabolic impairment in the cochlear base. Whether eliciting responses directly from regions with hair cell loss, or using high-level stimuli with cochlear excitation patterns that extend significantly basally into regions of hair cell loss, reduced suprathreshold responses may arise from a combination of synaptopathy and hair-cell based dysfunction. This problem may be addressed by using high-frequency masking noise, which reduces the ability of basal nerve fibers to synchronize to the ABR stimulus if the spatial locations of synaptopathy and hair cell loss do not overlap. There is currently no validated approach to electrophysiologically characterize synaptopathy in a region that also has hair cell loss, even in animal models.
Behavioral tests in human subjects that aim to measure the functional consequences of synaptopathy typically assume that the reduced number of IHC synapses degrades one's ability to track temporal features or other fine details of the stimulus. Although this is an emerging field of study, a few reports have found small but significant effects consistent with this idea (Bharadwaj et al., 2015; Liberman et al., 2016; Mehraei et al., 2016) . The human subjects in these studies were selected to have audiometrically normal hearing thresholds up to 8 kHz to ensure that synaptopathy would not be confounded by hair cell loss within that frequency range. The more general case of mixed pathology will be difficult to interpret with these types of experiments. OHC dysfunction or loss is known to affect the mechanics of the basilar membrane and degrade performance in timing-sensitive or certain speech-based tasks (Moore, 2007) . The contribution of synaptopathy vs. OHC dysfunction to degraded performance will be challenging to tease apart, and will require comparative analysis in a test-battery approach .
Auditory reflexes might prove useful in clinical assessment of synaptopathy. The middle ear muscle reflex (MEMR) has been used in clinical practice for decades, but has recently emerged as a potentially informative biomarker for synaptopathy. It has been suggested that the afferent limb of the MEMR is driven by activity across low-and medium-SR nerve fibers that is integrated in the cochlear nucleus and drives the efferent response via the facial and trigeminal nerves (Kobler et al., 1992; Valero et al., 2016) . This model potentially explains why MEMR thresholds can, in some cases, be unaffected in the presence of audiometric hearing loss (Popelka et al., 1976) : low-SR fiber supra-threshold responses to high-level stimuli are little affected by threshold elevation of up to 50 dB. In contrast, synaptopathy provides a potential explanation for MEMR threshold shifts without audiometric hearing loss: synaptopathy reduces the number of "channels" being integrated in the afferent limb and thus raises the sound pressure level required to reach threshold. This decoupling of hearing thresholds and MEMR thresholds provides a possible method to measure synaptopathy and hearing loss separately. More work is needed to test these ideas in practice.
How prevalent is cochlear synaptopathy in humans?
Though a key question for clinicians, scientists, and therapeutic developers, we will not be able to estimate the prevalence of synaptopathy in humans until a non-invasive diagnostic test for synaptic loss is identified. In lieu of such a validated proxy, is there another approach that would currently allow us to approximate the impact of synaptopathy on human health? Human temporal-bone studies suggest that loss of SGNs may begin as early as adolescence and continues throughout the lifespan, claiming 100 SGNs annually (Makary et al., 2011) . Because synaptic loss precedes SGN degeneration, proportional SGN loss underestimates true synapse loss. In this sense, most individuals in modern society live with some degree of auditory-nerve synaptic loss. But this same investigation suggested that there was also considerable variability in SGN survival, with some 40 year-olds presenting with losses that were more typical of nonagenarians and vice versa. Indeed, the average 30% loss of SGNs that occurred over the lifespan was matched by variability that extended over a 30% range around the mean in any given age group. It is intriguing to speculate that these differences in SGN survival might contribute to perceptual variability that is seen across many complex listening tasks where Type I afferent survival is predicted to impact performance (e.g. extracting signals from noise and fine spectrotemporal processing). But a direct relationship between synaptic loss and impaired suprathreshold perception has not been demonstrated. This precludes estimates of synaptopathy prevalence based on, for example, the frequency with which abnormal speech-in-noise perception is observed in the presence of normal audiometric thresholdsdas tempting as that might be.
Conclusions
The concept of cochlear synaptopathy has now been firmly established as a potentially important aspect of sensorineural hearing loss, but its impact on hearing abilities is only beginning to be understood. In animal models, a clear connection has been made between synaptic disconnection of IHCs and low-SR nerve fibers, and an impoverished transmission of sound through the auditory nerve, which can be measured as a reduction in ABR wave 1 amplitude in the context of normal auditory thresholds. More work is needed to understand the functional impact, prevalence, and ability to diagnose this condition in humans. It is not yet known with certainty whether the electrophysiological signature of synaptopathy presents the same in humans as in the animal models thus far developed; also, the TTS animal models inducing a restricted synaptopathy may not be a particularly good model of the human case, where a mixed pathology involving synapses, inner and outer hair cells, and possibly other cochlear structures might all co-occur. The impact of synaptopathy on hearing abilities might interact in complicated ways with other forms of cochlear damage, and it is not yet clear whether it will be possible to selectively diagnose and characterize these various forms of cochlear damage independently in the clinic. Theoretical considerations have led to the hypotheses that cochlear synaptopathy leads to an impairment in tasks involving temporal processing and/ or listening in noise, and some evidence from human studies along these lines is beginning to emerge.
